Evolent Health Inc. (NYSE:EVH) was down 1.1% during trading on Monday . The stock traded as low as $18.56 and last traded at $18.57, with a volume of 104,256 shares trading hands. The stock had previously closed at $18.78.

Several equities research analysts have recently commented on EVH shares. Leerink Swann reissued a “buy” rating and issued a $20.00 target price on shares of Evolent Health in a research note on Monday, May 16th. FBR & Co reissued a “buy” rating on shares of Evolent Health in a research note on Saturday, May 14th. Canaccord Genuity reissued a “buy” rating on shares of Evolent Health in a research note on Friday, May 13th. William Blair reissued a “buy” rating on shares of Evolent Health in a research note on Friday, March 18th. Finally, Zacks Investment Research raised Evolent Health from a “sell” rating to a “hold” rating in a research note on Wednesday, May 18th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Evolent Health has a consensus rating of “Buy” and an average target price of $17.80.

The firm has a 50-day moving average of $16.68 and a 200-day moving average of $12.35. The firm has a market cap of $1.11 billion and a PE ratio of 4.91.

Evolent Health (NYSE:EVH) last released its earnings results on Thursday, May 12th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.03. The business had revenue of $49.50 million for the quarter, compared to the consensus estimate of $47.40 million. The business’s revenue was up 33.8% compared to the same quarter last year. Equities research analysts predict that Evolent Health Inc. will post ($0.62) EPS for the current year.

An institutional investor recently raised its position in Evolent Health stock. Schroder Investment Management Group raised its stake in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Evolent Health worth $4,310,000 as of its most recent SEC filing.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.